Safety Trial of NK Cell Enhanced Donor Lymphocyte Infusions from a 3-5/6 HLA Matched Family Member Following Nonmyeloablative Allogeneic Stem Cell Transplantation
Publication
, Journal Article
Rizzieri, DA; Storms, R; Nikcevich, D; Peterson, B; Misra, D; Apple, C; Baker, M; Gasparetto, C; Horwitz, M; Chute, J; Morris, A; Chao, NJ
Published in: BLOOD
November 16, 2008
Duke Scholars
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 16, 2008
Volume
112
Issue
11
Start / End Page
133 / 134
Location
San Francisco, CA
Publisher
AMER SOC HEMATOLOGY
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Rizzieri, D. A., Storms, R., Nikcevich, D., Peterson, B., Misra, D., Apple, C., … Chao, N. J. (2008). Safety Trial of NK Cell Enhanced Donor Lymphocyte Infusions from a 3-5/6 HLA Matched Family Member Following Nonmyeloablative Allogeneic Stem Cell Transplantation. BLOOD, 112(11), 133–134.
Rizzieri, Davd A., Robert Storms, Daniel Nikcevich, Bercedis Peterson, Debashish Misra, Christine Apple, Megan Baker, et al. “Safety Trial of NK Cell Enhanced Donor Lymphocyte Infusions from a 3-5/6 HLA Matched Family Member Following Nonmyeloablative Allogeneic Stem Cell Transplantation.” BLOOD 112, no. 11 (November 16, 2008): 133–34.
Rizzieri DA, Storms R, Nikcevich D, Peterson B, Misra D, Apple C, et al. Safety Trial of NK Cell Enhanced Donor Lymphocyte Infusions from a 3-5/6 HLA Matched Family Member Following Nonmyeloablative Allogeneic Stem Cell Transplantation. BLOOD. 2008 Nov 16;112(11):133–4.
Rizzieri, Davd A., et al. “Safety Trial of NK Cell Enhanced Donor Lymphocyte Infusions from a 3-5/6 HLA Matched Family Member Following Nonmyeloablative Allogeneic Stem Cell Transplantation.” BLOOD, vol. 112, no. 11, AMER SOC HEMATOLOGY, Nov. 2008, pp. 133–34.
Rizzieri DA, Storms R, Nikcevich D, Peterson B, Misra D, Apple C, Baker M, Gasparetto C, Horwitz M, Chute J, Morris A, Chao NJ. Safety Trial of NK Cell Enhanced Donor Lymphocyte Infusions from a 3-5/6 HLA Matched Family Member Following Nonmyeloablative Allogeneic Stem Cell Transplantation. BLOOD. AMER SOC HEMATOLOGY; 2008 Nov 16;112(11):133–134.
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 16, 2008
Volume
112
Issue
11
Start / End Page
133 / 134
Location
San Francisco, CA
Publisher
AMER SOC HEMATOLOGY
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology